Page last updated: 2024-11-05

troglitazone and Berger Disease

troglitazone has been researched along with Berger Disease in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Xiao, J	1
Leung, JC	1
Chan, LY	1
Guo, H	1
Lai, KN	1

Other Studies

1 other study available for troglitazone and Berger Disease

Article	Year
Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:7 Topics: Cells, Cultured; Chromans; Epithelial Cells; Female; Glomerulonephritis, IGA; Humans; Inflammation;	2009

Article

Year

Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:7

Topics: Cells, Cultured; Chromans; Epithelial Cells; Female; Glomerulonephritis, IGA; Humans; Inflammation;

2009